-
-
The FDA has approved bedaquiline, a first in class drug for the treatment of multidrug-resistant tuberculosis.
-
The risk of hip fracture goes up for about 6 weeks immediately after older people start taking antihypertensives.
-
After 4 years, the intensive lifestyle intervention resulted in a greater likelihood of partial remission of type 2 diabetes.
-
Zoledronic Acid Treatment of Osteoporosis in Men; Relapsing Lyme Disease: Fact or Fiction?; Hypertension and Gout
-
Sedentary time is associated with an increased risk of diabetes, cardiovascular disease, and cardiovascular and all-cause mortality.
-
This study does not support the hypothesis that high calcium intake increases coronary artery calcification
-
A randomized, controlled trial showed that moderate doses of simvastatin or pravastatin resulted in reduced energy or exertional fatigue in up to 40% of patients, especially in women.
-
The FDA has approved a new drug with a novel mechanism of action for the treatment of rheumatoid arthritis in patients intolerant to or who have had inadequate response to methotrexate. Tofacifinib is an oral Janus kinase (JAK) inhibitor and is marketed by Pfizer as Xeljanz.
-
In this small pilot study of patients who sought help for insomnia, most of the awakenings were actually caused by sleep-disordered breathing.